The 2012 BSR and BHPR guideline for the treatment of psoriatic arthritis with biologics

The 2012 BSR and BHPR guideline for the treatment of psoriatic arthritis with biologics - British Society for Rheumatology (BSR) & British Health Professionals in Rheumatology (BHPR)

These guidelines offer systematic and evidence-based recommendations for the prescription of anti-TNF therapies in adult PsA patients to support UK clinicians in their use. The guidelines cover adult patients with PsA affecting all domains of psoriatic disease. They provide a stepwise management plan giving clear advice on treatment, including inclusion/exclusion criteria for treatment, monitoring requirements and how to quantify response to biologics. They provide evidence-based advice for the use of anti-TNF therapies in difficult situations, including pregnancy and significant comorbidities. A review on the use of conventional DMARDs prior to the use of anti-TNF therapies was not undertaken.


Read full Guideline